COFB

Cofinimmo S.A. is one of Europe's largest listed healthcare real estate investment trusts, operating a portfolio valued at approximately EUR 4.5 billion spread across Belgium, France, the Netherlands, Germany, and Spain. With a market capitalization of roughly EUR 3.3 billion, the company sits in the BEL20 index on Euronext Brussels and benefits from the Belgian RREC (Regulated Real Estate Company) regime, which grants favorable tax treatment in exchange for strict distribution requirements and leverage limits. The company employs just 150 people. This is not a labor intensive business. It is a capital allocation vehicle dressed in healthcare clothing, and its structural logic depends entirely on the durability of its tenant relationships and the cost of the debt that finances them.

The central analytical question for Cofinimmo in 2026 is whether the company has emerged from the interest rate shock of 2022 to 2024 structurally intact or merely patched over. The numbers tell a dramatic story: net income swung from EUR 483 million in 2022 to negative EUR 55 million in 2023, then recovered to EUR 64 million in 2024 and surged to EUR 213 million in 2025. This volatility is not operational. Cofinimmo's rent collection remained stable throughout the cycle. The swings were driven almost entirely by fair value adjustments on the property portfolio, the accounting mirror of what happens when discount rates move violently in both directions. Strip away the revaluation noise, and the underlying EPRA earnings per share remained remarkably stable, hovering around EUR 6.20 to EUR 6.40 throughout the period. This is the L17X insight: Cofinimmo's reported earnings volatility conceals one of the most stable operating cash flow profiles in European real estate. The market periodically treats the company as a leveraged bet on interest rates, but the business itself is a toll booth on demographic aging.

With next earnings due on April 22, 2026, the company enters the reporting season trading at approximately EUR 85.80 per share, a meaningful recovery from the EUR 59.30 low within the 52 week range, but still well below the EUR 94.70 high. The stock trades at a price to book ratio of 0.86, meaning the market values Cofinimmo at a discount to its reported net asset value. A DCF model using standard assumptions produces a value of approximately EUR 46, which suggests that the current price is either unjustified or that the market is pricing in growth and stability that the model fails to capture. This tension, between the low DCF figure and the higher market price, reveals something important: investors are paying for the income stream, not for the asset base at liquidation value. For a REIT yielding 7.8% in dividends, that calculus has its own logic.